SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-19-006017
Filing Date
2019-03-29
Accepted
2019-03-29 14:01:45
Documents
95
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20181231_10k.htm 10-K 2445106
2 EXHIBIT 10.31 ex_138997.htm EX-10.31 58122
3 EXHIBIT 31.1 ex_138995.htm EX-31.1 8253
4 EXHIBIT 31.2 ex_138998.htm EX-31.2 8362
5 EXHIBIT 32.1 ex_138996.htm EX-32.1 4066
6 EXHIBIT 32.2 ex_138999.htm EX-32.2 3999
13 a1.jpg GRAPHIC 12436
14 nby20181231_10kimg001.gif GRAPHIC 18187
  Complete submission text file 0001437749-19-006017.txt   11138049

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nby-20181231.xml EX-101.INS 2514153
8 XBRL TAXONOMY EXTENSION SCHEMA nby-20181231.xsd EX-101.SCH 103962
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20181231_cal.xml EX-101.CAL 56991
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20181231_def.xml EX-101.DEF 636923
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20181231_lab.xml EX-101.LAB 567576
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20181231_pre.xml EX-101.PRE 676276
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 19715515
SIC: 2834 Pharmaceutical Preparations